Inventor · disambiguated record
Terence Flotte
Also filed as: FLOTTE TERENCE · FLOTTE TERENCE R
23 granted patents·13 pending applications·1,621 citations·filing 1992–2024
97Inventor score
Top patents by PatentIndex Score
36 records- 0198US10077452B2rAAV-based compositions and methodsUNIV MASSACHUSETTS·Filed 2016·Granted Sep 18, 2018·18 cites·17 claims
- 0298US9885057B2RAAV-based compositions and methods for treating alpha-1 anti-trypsin deficienciesUNIV MASSACHUSETTS·Filed 2015·Granted Feb 6, 2018·22 cites·20 claims
- 0398US9284357B2AAV's and uses thereofUNIV MASSACHUSETTS·Filed 2014·Granted Mar 15, 2016·134 cites·5 claims
- 0498US8734809B2AAV's and uses thereofGAO GUANGPING·Filed 2010·Granted May 27, 2014·259 cites·51 claims
- 0597US10597656B2RAAV-based compositions and methodsUNIV MASSACHUSETTS·Filed 2018·Granted Mar 24, 2020·12 cites·10 claims
- 0697US10480011B2Recombinant AAV variants and uses thereofUNIV MASSACHUSETTS·Filed 2015·Granted Nov 19, 2019·15 cites·11 claims
- 0797US5658776AGeneration of high titers of recombinant AAV vectorsTARGETED GENETICS CORP·Filed 1995·Granted Aug 19, 1997·529 cites·15 claims
- 0895US10689420B2AAV's and uses thereofUNIV MASSACHUSETTS·Filed 2018·Granted Jun 23, 2020·8 cites·18 claims
- 0995US10035825B2AAV's and uses thereofUNIV MASSACHUSETTS·Filed 2016·Granted Jul 31, 2018·18 cites·6 claims
- 1095US7094604B2Production of pseudotyped recombinant AAV virionsUNIV FLORIDA·Filed 2004·Granted Aug 22, 2006·214 cites·35 claims
- 1194US9226976B2RAAV-based compositions and methods for treating alpha-1 anti-trypsin deficienciesFLOTTE TERENCE·Filed 2012·Granted Jan 5, 2016·35 cites·13 claims
- 1291US5866696AModified adeno-associated virus vector capable of expression from a novel promoterUS HEALTH·Filed 1996·Granted Feb 2, 1999·83 cites·4 claims
- 1390US5587308AModified adeno-associated virus vector capable of expression from a novel promoterUS HEALTH·Filed 1992·Granted Dec 24, 1996·115 cites·10 claims
- 1490US2024240180A1Raav-based compositions and methodsUNIV MASSACHUSETTS·Filed 2024·Application pending·0 cites
- 1588US5989540AModified adeno-associated virus vector capable of expression from a novel promoterUS HEALTH·Filed 1995·Granted Nov 23, 1999·62 cites·7 claims
- 1686US11254939B2RAAV-based compositions and methodsUNIV MASSACHUSETTS·Filed 2020·Granted Feb 22, 2022·1 cites·20 claims
- 1783US11542525B2Recombinant AAV variants and uses thereofUNIV MASSACHUSETTS·Filed 2019·Granted Jan 3, 2023·1 cites·20 claims
- 1882US11920133B2RAAV-based compositions and methodsUNIV MASSACHUSETTS·Filed 2022·Granted Mar 5, 2024·0 cites·22 claims
- 1980US8137962B2Compositions for treating cystic fibrosisFLOTTE TERENCE R·Filed 2007·Granted Mar 20, 2012·12 cites·4 claims
- 2078US6165781AModified adeno-associated virus vector capable of expression from a novel promoterUS HEALTH·Filed 1999·Granted Dec 26, 2000·27 cites·8 claims
- 2174US6461606B1Materials and methods for gene therapyUNIV FLORIDA·Filed 1999·Granted Oct 8, 2002·28 cites·27 claims
- 2274US5990279AAmino-terminally truncated cystic fibrosis transmembrane conductance regulatorUS HEALTH·Filed 1995·Granted Nov 23, 1999·28 cites·3 claims
- 2373US11834474B2AAV's and uses thereofUNIV MASSACHUSETTS·Filed 2020·Granted Dec 5, 2023·0 cites·9 claims
- 2462US2009186002A1rAAV-delivered alpha-1-antitrypsin compositions and method for the treatment and prevention of diabetesUNIV FLORIDA·Filed 2007·Application pending·0 cites
- 2558US2003095949A1Adeno-associated viral vectors for the treatment and prevention of diabetesUNIV FLORIDA·Filed 2003·Application pending·0 cites
- 2657US2003082162A1rAAV compositions for gene therapyUNIV FLORIDA·Filed 2002·Application pending·0 cites
- 2755US2009111766A1Raav vector-based compositions and methods for the prevention and treatment of mammalian diseasesUNIV FLORIDA·Filed 2008·Application pending·0 cites
- 2853US2024216534A1Direct raav-mediated in vivo gene editing of hematopoietic stem cellsUNIV MASSACHUSETTS·Filed 2022·Application pending·0 cites
- 2952US2007015238A1Production of pseudotyped recombinant AAV virionsSNYDER RICHARD O·Filed 2003·Application pending·0 cites
- 3051US2021393805A1Perfusion-based delivery of recombinant aav vectors for expression of secreted proteinsUNIV MASSACHUSETTS·Filed 2019·Application pending·0 cites
- 3148US11884926B2Campaign-ready series of recombinant adeno-associated virus (rAAV) complementing plasmidsUNIV MASSACHUSETTS·Filed 2019·Granted Jan 30, 2024·0 cites·18 claims
- 3248US2004142416A1Treatment for phenylketonuriaFiled 2003·Application pending·0 cites
- 3347US2006292117A1Improved rAAv vectorsLOILER SCOTT A·Filed 2003·Application pending·0 cites
- 3446US2004072351A1Methods and compositions for expressing a nucleic acid in a dendritic cellFiled 2003·Application pending·0 cites
- 3546US2007003518A1Raav vector-based compositions and methods for the prevention and treatment of mammalian diseasesATKINSON MARK A·Filed 2003·Application pending·0 cites
- 3643US2022220170A1Aav capsid chimeric antigen receptors and uses thereofUNIV MASSACHUSETTS·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Terence Flotte files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →